PREPARATION AND IMMUNOGENICITY OF A BIVALENT CELL-SURFACE PROTEIN-POLYSACCHARIDE CONJUGATE OF VIBRIO-CHOLERAE

被引:16
|
作者
KABIR, S [1 ]
机构
[1] INT CTR DIARRHOEAL DIS RES,DHAKA,BANGLADESH
关键词
D O I
10.1099/00222615-23-1-9
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
引用
收藏
页码:9 / 18
页数:10
相关论文
共 42 条
  • [21] Vibrio cholerae O139 conjugate vaccines:: Synthesis and immunogenicity of V-cholerae O139 capsular polysaccharide conjugates with recombinant diphtheria toxin mutant in mice
    Kossaczka, Z
    Shiloach, J
    Johnson, V
    Taylor, DN
    Finkelstein, RA
    Robbins, JB
    Szu, SC
    INFECTION AND IMMUNITY, 2000, 68 (09) : 5037 - 5043
  • [22] Plasma cell antibody repertoire analysis following administration of meningococcal polysaccharide and protein-polysaccharide conjugate vaccines: evidence of distinct patterns of B cell activation
    Galson, J. D.
    Clutterbuck, E. A.
    Trueck, J.
    Muenz, M.
    Fowler, A.
    Cerundolo, V.
    Pollard, A. J.
    Lunter, G.
    Kelly, D. F.
    IMMUNOLOGY, 2014, 143 : 62 - 62
  • [23] Immunomodulation of T-cell responses with Vibrio cholerae O135 capsular polysaccharide and its protein conjugate, novel cholera vaccine study models
    Paulovicova, Ema
    Korcova, Jana
    Machova, Eva
    Bystricky, Slavomir
    FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY, 2012, 65 (03): : 422 - 430
  • [24] PRODUCTION OF VIBRIO-CHOLERAE O1 AND NON-O1 TYPING SERA IN RABBITS IMMUNIZED WITH POLYSACCHARIDE-PROTEIN CARRIER CONJUGATES
    ADAMS, LB
    SIEBELING, RJ
    JOURNAL OF CLINICAL MICROBIOLOGY, 1984, 19 (02) : 181 - 186
  • [25] AFFINITY PREPARATION OF A PROTEIN INHIBITOR RECOGNIZING A CELL-SURFACE PROTEASE
    STEVEN, FS
    GRIFFIN, MM
    BELL, J
    TALBOT, IC
    JOURNAL OF ENZYME INHIBITION, 1993, 7 (01): : 65 - 76
  • [26] SAFETY AND IMMUNOGENICITY OF A LIVE ORAL BIVALENT TYPHOID-FEVER (SALMONELLA-TYPHI TY21A) CHOLERA (VIBRIO-CHOLERAE CVD 103-HGR) VACCINE IN HEALTHY-ADULTS
    CRYZ, SJ
    QUE, JU
    LEVINE, MM
    WIEDERMANN, G
    KOLLARITSCH, H
    INFECTION AND IMMUNITY, 1995, 63 (04) : 1336 - 1339
  • [27] CELL-MEDIATED-IMMUNITY AFTER ORAL IMMUNIZATION WITH RIBONUCLEIC ACID PROTEIN FRACTIONS OF VIBRIO-CHOLERAE L-FORM LYSATES
    AGARWAL, SC
    SUNDARARAJ, T
    INFECTION AND IMMUNITY, 1977, 16 (02) : 527 - 530
  • [28] CAPSULAR POLYSACCHARIDE-PROTEIN CONJUGATE VACCINES OF CARBOTYPE-1 VIBRIO-VULNIFICUS - CONSTRUCTION, IMMUNOGENICITY, AND PROTECTIVE EFFICACY IN A MURINE MODEL
    DEVI, SJN
    HAYAT, U
    FRASCH, CE
    KREGER, AS
    MORRIS, JG
    INFECTION AND IMMUNITY, 1995, 63 (08) : 2906 - 2911
  • [29] POLYSACCHARIDE-IRON-REGULATED CELL-SURFACE PROTEIN CONJUGATE VACCINE - ITS ROLE IN PROTECTION AGAINST KLEBSIELLA PNEUMONIAE-INDUCED LOBAR PNEUMONIA
    CHHIBBER, S
    BAJAJ, J
    VACCINE, 1995, 13 (02) : 179 - 184
  • [30] The magnitude of the antibody and memory B cell responses during priming with a protein-polysaccharide conjugate vaccine in human infants is associated with the persistence of antibody and the intensity of booster responsele
    Rohner, Geraldine Blanchard
    Snape, Matthew D.
    Kelly, Dominic F.
    John, Tessa
    Morant, Anita
    Yu, Ly-Mee
    Borkowski, Astrid
    Ceddia, Francesca
    Borrow, Ray
    Siegrist, Claire-Anne
    Pollard, Andrew J.
    JOURNAL OF IMMUNOLOGY, 2008, 180 (04): : 2165 - 2173